Podomed
ActiveSummary
Podomed has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €7,587 and a net result of €31,097. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 11% of 16765 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability98▼-2
Solvency31▼-69
Growth58▼-20
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €500 at 30 days acceptable
Liquidity short (current ratio 0.87 against 5.31 in 2024; short-term debt: 94.2% and cash: 81.7% of total assets), and 94.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
5.8%
Return on assets
23.6%
Age of the figures
12 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 11% of 16765 sector peers (2025).
NBB · sector comparisonPosition among 16765 sector peers
Solvency
better than 11%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 01-04-2026, 29 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
29 d early
2024
30 d early
2023
28 d early
2022
4 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 4 accounts on average 23 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today. Usually files around 2 April (4 of the last 4 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today30-09-2026 close30-04-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€31,097▲ 11.8%
2024 · €27,817
Working capital
-€16,294
2024 · €67,980
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line2022202320242025
Operating result€34,384-€33,514▼ 2.5%€37,294▲ 11.3%€41,886▲ 12.3%
Net result€26,409within the sector's middle half-€25,265within the sector's middle half▼ 4.3%€27,817within the sector's middle half▲ 10.1%€31,097within the sector's middle half▲ 11.8%
Equity€28,409below the sector's middle half-€53,674within the sector's middle half▲ 88.9%€81,490within the sector's middle half▲ 51.8%€7,587below the sector's middle half▼ 90.7%
Total assets€52,191below the sector's middle half-€77,652below the sector's middle half▲ 48.8%€98,242below the sector's middle half▲ 26.5%€131,739within the sector's middle half▲ 34.1%
Debt€23,782-€23,978▲ 0.8%€16,752▼ 30.1%€124,152▲ 641%
Working capital€20,988within the sector's middle half-€45,895within the sector's middle half▲ 119%€67,980within the sector's middle half▲ 48.1%-€16,294below the sector's middle half
Solvency54.4%within the sector's middle half-69.1%within the sector's middle half▲ 14.7pp82.9%within the sector's middle half▲ 13.8pp5.8%below the sector's middle half▼ 77.2pp
Current ratio1.88within the sector's middle half-2.91within the sector's middle half▲ 1.035.31within the sector's middle half▲ 2.400.87below the sector's middle half▼ 4.44
Return on assets (ROA)50.6%above the sector's middle half-32.5%within the sector's middle half▼ 18.1pp28.3%within the sector's middle half▼ 4.2pp23.6%within the sector's middle half▼ 4.7pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 12% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €131,739
Fixed assets
€23,881 ▲ 64.7%
Current assets
€107,858 ▲ 28.8%
Equity and liabilities €131,739
Equity
€7,587 ▼ 90.7%
Debt
€124,152 ▲ 641%
Debt's share of the balance-sheet total rises from 17.1% to 94.2%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€47,445▲
2024 · €42,743
Cash flow
€36,656▲
2024 · €33,265
Debt to equity
16.36▲
2024 · 0.21
ROE
409.9%▲
2024 · 34.1%
Interest coverage
232.42▲
2024 · 73.01
Debt ≤ 1 year
€124,152▲
2024 · €15,762
Income taxes
€10,584▲
2024 · €8,892
Staff costs
€2,409▲
2024 · €698
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 2,157 companies that looked in July 2024 the way this one looks now, 3.0% went bankrupt within 24 months and 94% are still going.
- Micro
- 2 to 5 years old
- solvency under 10%
- a profit of 5% of the balance sheet or more
3.0%
went bankrupt
2.8%
stopped otherwise
94%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 2,157 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €863 | €698 | €2,409 | ▲ 245% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €5,386 | €5,672 | €5,449 | €5,559 | ▲ 2.0% |
| Other operating charges640/8 | €6,564 | €5,193 | €8,491 | €10,358 | ▲ 22.0% |
| Gross operating margin9900 | €46,334 | €45,242 | €51,933 | €60,211 | ▲ 15.9% |
| Operating profit (loss)9901 | €34,384 | €33,514 | €37,294 | €41,886 | ▲ 12.3% |
| Financial income75/76B | - | - | €0 | - | - |
| Recurring financial income75 | - | - | €0 | - | - |
| Financial charges65/66B | €325 | €349 | €585 | €204 | ▼ 65.1% |
| Recurring financial charges65 | €325 | €349 | €585 | €204 | ▼ 65.1% |
| Profit (loss) for the period before taxes9903 | €34,059 | €33,165 | €36,709 | €41,682 | ▲ 13.5% |
| Income taxes67/77 | €7,650 | €7,900 | €8,892 | €10,584 | ▲ 19.0% |
| Profit (loss) for the period9904 | €26,409 | €25,265 | €27,817 | €31,097 | ▲ 11.8% |
| Profit (loss) for the period to be appropriated9905 | €26,409 | €25,265 | €27,817 | €31,097 | ▲ 11.8% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €52,191 | €77,652 | €98,242 | €131,739 | ▲ 34.1% |
| Fixed assets21/28 | €7,421 | €7,779 | €14,500 | €23,881 | ▲ 64.7% |
| Tangible fixed assets22/27 | €7,421 | €7,779 | €14,500 | €23,881 | ▲ 64.7% |
| Plant, machinery and equipment23 | €6,842 | €5,784 | €5,452 | €10,534 | ▲ 93.2% |
| Furniture and vehicles24 | €578 | €1,995 | €8,139 | €12,534 | ▲ 54.0% |
| Other tangible fixed assets26 | - | - | €908 | €813 | ▼ 10.5% |
| Current assets29/58 | €44,770 | €69,873 | €83,742 | €107,858 | ▲ 28.8% |
| Amounts receivable within one year40/41 | €516 | €7,410 | €12,030 | €184 | ▼ 98.5% |
| Trade receivables40 | €516 | €7,410 | €12,030 | €184 | ▼ 98.5% |
| Cash at bank and in hand54/58 | €44,254 | €62,463 | €71,712 | €107,674 | ▲ 50.1% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €52,191 | €77,652 | €98,242 | €131,739 | ▲ 34.1% |
| Equity10/15 | €28,409 | €53,674 | €81,490 | €7,587 | ▼ 90.7% |
| Contributions10/11 | €2,000 | €2,000 | €2,000 | €2,000 | = |
| Capital10 | €2,000 | - | - | - | - |
| Issued capital100 | €2,000 | - | - | - | - |
| Outside capital11 | - | €2,000 | - | - | - |
| Other1109/19 | - | €2,000 | - | - | - |
| Reserves13 | €200 | €200 | €200 | €200 | = |
| Non-distributable reserves130/1 | €200 | €200 | €200 | €200 | = |
| Legal reserve130 | €200 | €200 | - | - | - |
| Reserves not available under the articles1311 | - | - | €200 | €200 | = |
| Profit (loss) carried forward14 | €26,209 | €51,474 | €79,290 | €5,387 | ▼ 93.2% |
| Amounts payable17/49 | €23,782 | €23,978 | €16,752 | €124,152 | ▲ 641% |
| Amounts payable within one year42/48 | €23,782 | €23,978 | €15,762 | €124,152 | ▲ 688% |
| Trade debts44 | €2,697 | €3,278 | €4,062 | €4,122 | ▲ 1.5% |
| Suppliers440/4 | €2,697 | €3,278 | €4,062 | €4,122 | ▲ 1.5% |
| Taxes, remuneration and social security45 | €13,232 | €18,069 | €11,650 | €29,042 | ▲ 149% |
| Taxes450/3 | €11,132 | €15,983 | €9,564 | €26,956 | ▲ 182% |
| Remuneration and social security454/9 | €2,100 | €2,087 | €2,087 | €2,087 | = |
| Other amounts payable47/48 | €7,852 | €2,631 | €50 | €90,987 | ▲ 181,874% |
| Accrued charges and deferred income492/3 | - | - | €990 | - | - |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €26,409 | €25,265 | €27,817 | €31,097 | ▲ 11.8% |
| + Depreciation and write-downs630 | €5,386 | €5,672 | €5,449 | €5,559 | ▲ 2.0% |
| Operating cash flow (approximation) | €31,795 | €30,937 | €33,265 | €36,656 | ▲ 10.2% |
| Investment in fixed assets (approximation) | - | -€6,031 | -€12,170 | -€14,940 | ▼ 22.8% |
| Change in cash | - | €18,209 | €9,249 | €35,961 | ▲ 289% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
01-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
Financial
Highest result since 2022net €31,097 ▲11.8%
Operating result €41,886, net result €31,097, both a record.
31-03
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
02-04
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-09
Financial
Weakest financial yearnet €25,265 ▼4.3%
Net result drops to €25,265, the lowest in the series; recovery starts the following year.
26-04
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Chaumont-Gistoux
Ground area
957 m²
Building footprint
143 m²
Volume, LiDAR
860 m³
Parcel 25025A0135/00G000, Wallonia · tallest building 8.3 m, ±2 floors. Linked by address, not a title deed.
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25025A0135/00G000 | Wallonia | 957 m² | 1 · 142 m² | 8.3 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
GHCD België
BE 0797.797.977
Tessenderlo-Ham · Eq €7,628
Podologie Forest House
BE 0508.820.230
Brussel · Eq €7,546
Kiné Eline Cuelenaere
BE 0781.367.860
Sint-Laureins · Eq €7,500
Kine Enbiya Demirayak
BE 1003.539.234
Antwerpen · Eq €7,682
KINAIR
BE 0781.764.768
Meerhout · Eq €7,702
Of 12,698 companies in sector 86951 we hold annual accounts for 2,146. 1,368 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded19-10-2021
Fiscal year end30-09
Activities, NACEBEL 2025
86951Physiotherapy
E-invoicing
Reachable via Peppol
Peppol ID
0208:0775891122
Registered
16-11-2021
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.